Refined Stratification and Frontline Targeted Therapies Explored in Pediatric T-ALL

The treatment of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) has benefited from numerous advancements in survival outcomes, but there are pressing needs for better risk assessment and the use of targeted therapies in the frontline setting.

Read more: https://www.targetedonc.com/view/refined-stratification-and-frontline-targeted-therapies-explored-in-pediatric-t-all